89
2
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T40786 |
CXCR4 antagonist 1
CXCR4 antagonist 1 |
||
CXCR4 antagonist 1 is a potent inhibitor of the CXCR4 receptor, with notable anti-HIV activity. | |||
T39742 | CXCR4 antagonist 2 | ||
CXCR4 antagonist 2 is a CXCR4 antagonist with an IC 50 value of 47 nM. | |||
T83763 |
EPI-X4 TFA
Endogenous Peptide Inhibitor of CXCR4 |
||
EPI-X4是一种源于人血清白蛋白408-423氨基酸的内源性肽段,是趋化因子(C-X-C基序)受体4 (CXCR4)的拮抗剂。在0.8至1,000µM的浓度范围内,EPI-X4能抑制表达CXCR4的HEK293细胞中由趋化因子(C-X-C基序)配体12 (CXCL12)诱发的钙离子动员和受体内化。EPI-X4还能抑制CXCL12诱导的Jurkat T细胞和人类CD34+造血干细胞的迁移。体内实验中,EPI-X4(16µmol/kg)在急性过敏性气道高嗜酸性粒细胞疾病的小鼠模型中减少了Cxcr4依赖的炎症细胞气道浸润。慢性肾脏病患者尿液中EPI-X4的水平增高,并与肾小球滤过率(GFR)成反比。 | |||
T64306 |
CXCR4 probe 1
|
||
CXCR4 probe 1 (compound 5) 是一种有效地、特异性的 CXCR4 靶向 PET 示踪剂,能够作用于 CXCR4 特异性拮抗剂 TN14003 (IC50: 6.9 nM)。CXCR4 probe 1 具有潜力作为 CXCR4 特异性成像探针,用于炎性疾病、CXCR4 阳性肿瘤和转移性肿瘤的诊断和预后监测。 | |||
T61420 |
CXCR4 antagonist 6
|
||
CXCR4 antagonist 6 (compound 46) is a highly potent inhibitor of CXCR4 with an IC50 value of 79 nM. It effectively inhibits the cytosolic calcium flux induced by CXCL12, achieving an IC50 of 0.25 nM. Moreover, CXCR4 antagonist 6 demonstrates significant mitigation of cell migration mediated by the CXCL12/CXCR4 interaction. Notably, this compound exhibits remarkable efficacy in a mouse model of cancer metastasis [1]. | |||
T61409 | CXCR4 antagonist 3 | ||
CXCR4 antagonist 3 (compound 12a), an effective antagonist of CXCR4, exhibits an IC50 of 11 nM. It is a congener of TIQ15, showcasing exceptional properties such as CXCR4 antagonism, CYP 2D6 inhibition, metabolic stability, and permeability. With its potential for research on the human immunodeficiency virus, CXCR4 antagonist 3 holds great promise [1]. | |||
T61363 |
CXCR4 antagonist 8
|
||
CXCR4 antagonist 8 (Compound 3) is a potent inhibitor of CXCR4. It demonstrates an IC50 value of 57 nM in CXCR4 antagonism. In addition, it effectively inhibits the increase in cytosolic calcium induced by CXCL12 with an IC50 value of 0.24 nM. Furthermore, Compound 3 shows efficacy in the inhibition of CXCL12/CXCR4-mediated cell migration [1]. | |||
T63369 |
CXCR4 antagonist 4
|
||
CXCR4 antagonist 4 是口服具有活力的、有效的CXCR4拮抗剂,IC50 值为 24 nM。CXCR4 antagonist 4能够抑制 CYP 2D6 的活性,增加 PAMPA 的通透性,有效阻碍人类免疫缺陷病毒的进入 (IC50=7 nM)。 | |||
T62352 |
CXCR4 modulator-2
|
||
CXCR4 modulator-2 (compound Z7R) 是一种 CXCR4 的高效调节剂 (IC50: 1.25 nM)。CXCR4 modulator-2 在小鼠血清中表现出较好的稳定性 (t1/2= 77.1 min),在小鼠水肿模型中具有抗炎作用。 | |||
T62007 |
CXCR4 modulator-1
|
||
CXCR4 modulator-1 (compound ZINC72372983) 是有效的CXCR4调节剂(EC50= 100 nM)。CXCR4 modulator-1 在抗炎、抗癌及抗 HIV 感染方面有研究价值。 | |||
T61419 | CXCR4 antagonist 5 | ||
CXCR4 antagonist 5 (compound 23), a potent CXCR4 antagonist, exhibits high inhibition efficacy against CXCR4 with an IC50 value of 8.8 nM. It effectively suppresses CXCL12-induced cytosolic calcium increase (IC50 = 0.02 nM) and hinders CXCR4/CXCL12-mediated chemotaxis. Moreover, Compound 23 demonstrates favorable physicochemical properties and in vitro safety profiles, exhibiting only marginal to moderate inhibition of CYP isozymes and hERG [1]. | |||
T61650 | CXCR4 antagonist 9 | ||
CXCR4 antagonist 9 (Compound 2) is a potent CXCR4 antagonist displaying an IC50 of 15 nM. It effectively inhibits the cytosolic calcium increase induced by CXCL12, with an IC50 value of 1.3 nM [1]. | |||
T60811 |
CXCR4 antagonist 7
|
||
CXCR4 antagonist 7 (Compound PARA-B) 是可用于研究HIV 感染、炎症性疾病、癌症和 WHIM 综合症的CXCR4拮抗剂 (IC50 = 9.3 nM)。 | |||
T78879 |
CXCR4-IN-2
|
CXCR | Autophagy; GPCR/G Protein; Immunology/Inflammation |
CXCR4-IN-2(compound A1)是一款具有抗癌活性的双功能氟化小分子,是CXCR4的强效抑制剂。它对小鼠结直肠癌(CRC)细胞展现出显著的细胞毒性(IC50:60 μg/mL;72小时)和抗增殖能力,能够引导细胞在G2/M期发生阻滞并诱导细胞凋亡(apoptosis)。 | |||
T80216 |
DOTA-CXCR4-L
|
CXCR | Autophagy; GPCR/G Protein; Immunology/Inflammation |
DOTA-CXCR4-L为针对CXCR4的靶向肽,适用于癌症研究,如胶质母细胞瘤和三阴性乳腺癌。 | |||
T79059 | CXCR4-IN-1 | CXCR | Autophagy; GPCR/G Protein; Immunology/Inflammation |
CXCR4-IN-1 (Example C5) 为CXCR4抑制剂,IC50值为20 nM。该化合物主要适用于癌症、HIV、糖尿病视网膜病变、炎症等领域的研究。 | |||
T4032 |
MSX-127
MSX 127 |
CXCR | Autophagy; GPCR/G Protein; Immunology/Inflammation |
MSX-127 是一种CXCR4拮抗剂,可抑制肿瘤转移。 | |||
T4033 |
MSX-130
MSX 130 |
CXCR | Autophagy; GPCR/G Protein; Immunology/Inflammation |
MSX-130 是一种CXCR4拮抗剂,可抑制肿瘤转移。 | |||
T15805L |
LY2510924 acetate(1088715-84-7 free base)
|
CXCR | Autophagy; GPCR/G Protein; Immunology/Inflammation |
LY2510924 acetate(1088715-84-7 free base) 是一种有效的选择性 CXCR4 拮抗剂。它可防止 SDF-1 与 CXCR4 结合,IC50 为 0.079 nM。 | |||
T3992 |
MSX-122
MSX 122,MSX122 |
CXCR | Autophagy; GPCR/G Protein; Immunology/Inflammation |
MSX-122 是可口服的CXCR4部分拮抗剂,具有抗炎和抗转移活性,可抑制CXCR4/CXCL12相互作用,IC50值约为 10 nM。 | |||
TP1348 |
FC131 TFA (606968-52-9 free base)
FC131 TFA |
HIV Protease; CXCR | Autophagy; GPCR/G Protein; Immunology/Inflammation; Microbiology/Virology; Proteases/Proteasome |
FC131 TFA (606968-52-9 free base) (FC131 TFA) 是 CXCR4 的拮抗剂,可抑制 [125I] -sdf-1 与 CXCR4 的结合(IC50:4.5 nM),并具有抗 HIV 活性。 | |||
T1739 |
WZ811
|
CXCR | Autophagy; GPCR/G Protein; Immunology/Inflammation |
WZ811 是可口服的高竞争性CXCR4拮抗剂,抑制细胞中 CXCR4/SDF-1 介导的 cAMP 水平调节和 SDF-1 诱导的基质胶侵入,EC50为 1.2 和 5.2 nM。 | |||
T11693L |
IT1t dihydrochloride
|
CXCR | Autophagy; GPCR/G Protein; Immunology/Inflammation |
IT1t dihydrochloride 抑制 CXCL12/CXCR4 相互作用,IC50 为 2.1 nM。 IT1t dihydrochloride 是 CXCR4 的拮抗剂。 | |||
T14665L |
Motixafortide TFA(664334-36-5,Free)
TF 14016 TFA,BKT140 TFA,BL-8040 TFA,T140 TFA |
CXCR | Autophagy; GPCR/G Protein; Immunology/Inflammation |
Motixafortide TFA(664334-36-5,Free) (BKT140 TFA) 是 CXCR4 的拮抗剂,IC50 为 ~1 nM。它通过改变 miR-15a/16-1 表达下调 ERK、BCL-2、MCL-1 和 cyclin-D1 来诱导 AML 原始细胞凋亡。 | |||
T17208 |
USL311
|
CXCR | Autophagy; GPCR/G Protein; Immunology/Inflammation |
USL311 是选择性 CXCR4拮抗剂,可防止基质细胞衍生因子 1(SDF-1 或 CXCL12)与 CXCR4 结合。它抑制 CXCR4 活化并减少表达 CXCR4 的肿瘤细胞的增殖和迁移,具有抗肿瘤活性。 | |||
T1776L |
Plerixafor octahydrochloride
盐酸普乐沙福,JM3100 octahydrochloride,Plerixafor 8HCl (AMD3100 8HCl),Plerixafor 8HCl,SID791 octahydrochloride,AMD 3100 octahydrochloride,JM 3100 8HCl |
Virus Protease; HIV Protease; CXCR | Autophagy; GPCR/G Protein; Immunology/Inflammation; Microbiology/Virology; Proteases/Proteasome |
Plerixafor octahydrochloride (JM3100 octahydrochloride) 是一种选择性的CXCR4拮抗剂,IC50为 44 nM。Plerixafor 是一种具有造血干细胞动员活性的双环霉素。 | |||
T1776 |
Plerixafor
普乐沙福,JM3100,AMD 3100,AMD-3329 |
Virus Protease; HIV Protease; CXCR | Autophagy; GPCR/G Protein; Immunology/Inflammation; Microbiology/Virology; Proteases/Proteasome |
Plerixafor (AMD-3329) 是一种趋化因子受体拮抗剂,可阻断基质细胞衍生因子与细胞受体 CXCR4 的结合。它也是 CXCR7 的变构激动剂,是免疫刺激剂和造血干细胞动员剂,还抑制HIV-1和HIV-2的复制,EC50为 1-10 nM。 | |||
TQ0174 |
Mavorixafor
AMD-070 |
CXCR | Autophagy; GPCR/G Protein; Immunology/Inflammation |
Mavorixafor (AMD-070) 是一种有效的特异性 CXCR4 拮抗剂,对 CXCR4 125I-SDF 结合的 IC50 值为 13 nM。 Mavorixafor 在 MT-4 细胞 (IC50 = 1 nM) 和 PBMC (IC50 = 9 nM) 中抑制 T-tropic HIV-1 (NL4.3 株) 的复制。 | |||
TP2051L |
CTCE 9908 acetate
|
CXCR | Autophagy; GPCR/G Protein; Immunology/Inflammation |
CTCE 9908 acetate 是 CXCR4 的拮抗剂,可抑制表达 CXCR4 的卵巢癌细胞的迁移。 | |||
T7208 |
AMD 3465 hexahydrobromide
GENZ-644494 (hexahydrobromide) |
HIV Protease; CXCR | Autophagy; GPCR/G Protein; Immunology/Inflammation; Microbiology/Virology; Proteases/Proteasome |
AMD 3465 hexahydrobromide (GENZ-644494 (hexahydrobromide)) 是一种 CXCR4受体拮抗剂,具有潜在的抗癌和抗 HIV 活性。 | |||
TP2112L |
TC14012 acetate
TC14012 acetate(368874-34-4 free base) |
CXCR; Arrestin | Autophagy; GPCR/G Protein; Immunology/Inflammation |
TC14012 acetate 是 T140 的血清稳定衍生物,是一种选择性的肽模拟 CXCR4 拮抗剂,IC50 为 19.3 nM。 TC14012 还是一种有效的 CXCR7 激动剂,EC50 为 350 nM,可将 β-arrestin 2 募集到 CXCR7。 TC14012 具有抗癌活性和抗 HIV 活性。 | |||
T5207 |
LIT927
LIT 927,LIT-927 |
CXCR | Autophagy; GPCR/G Protein; Immunology/Inflammation |
LIT927 (LIT-927) 是一种具有口服活性的 CXCL12 中性配体(对于 CXCL12 与 CXCR4 的结合,Ki:267 nM)。 | |||
T22565 |
AMD-070 hydrochloride
N-(1H-苯并咪唑-2-基甲基)-N-[(8S)-5,6,7,8-四氢-8-喹啉基]-1,4-丁二胺单盐酸盐 |
CXCR | Autophagy; GPCR/G Protein; Immunology/Inflammation |
AMD-070 hydrochloride 是一种 CXCR4 拮抗剂,可用于抗 HIV。 | |||
T12269 |
NUCC-390
|
CXCR | Autophagy; GPCR/G Protein; Immunology/Inflammation |
NUCC-390 是新型的选择性小分子 CXCR4 receptor 受体激动剂。NUCC-390 可以诱导 CXCR4 受体的内化,作用方式与 AMD3100相反。NUCC-390 在动物模型中,有助于神经退行性变后神经功能恢复。 | |||
T76794 |
Ulocuplumab
BMS 936564,MDX 1338 |
Apoptosis; CXCR | Apoptosis; Autophagy; GPCR/G Protein; Immunology/Inflammation |
Ulocuplumab (BMS-936564) 是一种完全人 抗 CXCR4 的 IgG4 抗体。Ulocplumab 在急性髓系白血病 (AML),非霍奇金淋巴瘤 (NHL) 和多发性骨髓瘤移植模型中展现出抗肿瘤活性。Ulocplumab 对 CXCL12 介导的慢性淋巴细胞白血病 (CLL) 细胞在 CXCR4 激活下的迁移有抑制作用,诱导癌细胞凋亡 (apoptosis),。 | |||
T9721 |
ML339
|
CXCR | Autophagy; GPCR/G Protein; Immunology/Inflammation |
ML339 是有效的CXCR6选择性拮抗剂,IC50为 140 nM。ML339 对 CXCR5,CXCR4,CCR6 和 Apelin 受体 (APJ) 无拮抗作用,IC50>79 μM。ML339 在前列腺癌研究领域有研究的价值。 | |||
T6764L |
ATI-2341 acetate(1337878-62-2 free base)
|
CXCR | Autophagy; GPCR/G Protein; Immunology/Inflammation |
ATI-2341 acetate(1337878-62-2 free base) 是一种有效的 CXCR4 变构激动剂,它激活 Gα1 而不是 Gα13。 ATI-2341 acetate 激活抑制性异源三聚体 G 蛋白 (GI) 以促进对 cAMP 产生的抑制并诱导钙动员。 | |||
TP1364L |
ALX 40-4C acetate
ALX 40-4C acetate(143413-49-4 free base) |
Apelin receptor; CXCR | Autophagy; GPCR/G Protein; Immunology/Inflammation |
ALX 40-4C acetate 是趋化因子受体 (Ki = 1 μM) 的 CXCR4 抑制剂,可抑制 HIV-1 X4 株的复制。 ALX 40-4C acetate 是 APJ 受体的拮抗剂 (IC50 = 2.9 μM)。 | |||
T2375 |
BX471
BX 471,BX-471,ZK-811752 |
CCR | Immunology/Inflammation; Microbiology/Virology |
BX471 (BX 471) 是可口服的非多肽 CCR1选择性拮抗剂,Ki 值为 1 nM,对其选择性是对 CCR2、CCR5 和 CXCR4 的 250 倍。 | |||
T20482L |
Acth (1-4) acetate(19405-50-6 free base)
|
Others | Others |
Acth (1-4) acetate(19405-50-6 free base) 是 ACTH N 端四肽。 | |||
T15805 |
LY2510924
|
Others | Others |
LY2510924 is an effective and selective CXCR4 antagonist. It blocks SDF-1 binding to CXCR4 (IC50: 0.079 nM). | |||
T22777 |
FC131
FC 131 |
Others | Others |
CXCR4 antagonist | |||
T14665 |
Motixafortide
BL-8040,BKT140 (4-fluorobenzoyl),TF14016 |
CXCR | Autophagy; GPCR/G Protein; Immunology/Inflammation |
Motixafortide (BKT140 4-fluorobenzoyl) is an antagonist of CXCR4 (IC50: 1 nM). | |||
TP2141 |
Balixafortide TFA (1051366-32-5 free base)
Balixafortide TFA,POL6326 TFA |
CXCR | Autophagy; GPCR/G Protein; Immunology/Inflammation |
Balixafortide TFA (POL6326 TFA) is a selective, well-tolerated peptidic CXCR4 antagonist (IC50 < 10 nM). It shows 1000-fold selective for CXCR4 than a large panel of receptors including CXCR7. Balixafortide TFA blocks β-arrestin recruitment and calcium fl | |||
T6764 |
ATI-2341
ATI2341 |
CXCR | Autophagy; GPCR/G Protein; Immunology/Inflammation |
ATI-2341 是 C-X-C 趋化因子受体 4 型功能选择性变构激动剂,作为偏向配体有利于 Gα1 激活。它是一种变构激动剂,可激活抑制性异源三聚体 G 蛋白 (Gi) 以促进抑制 cAMP 产生并诱导钙动员。 | |||
T11693 |
IT1t
|
Others | Others |
IT1t inhibits CXCL12/CXCR4 interaction with an IC50 of 2.1 nM. is a potent CXCR4 antagonist. | |||
TP2141L |
Balixafortide
POL6326 |
CXCR | Autophagy; GPCR/G Protein; Immunology/Inflammation |
Balixafortide (POL6326) is a potent, selective, well-tolerated peptidic CXCR4 antagonist with an IC50 < 10 nM and it is also a potent hematopoietic stem and progenitor cell (HSPC) mobilizing agent. Anti-cancer effects[1][2]. Balixafortide blocks β-arresti | |||
T39787 |
KRH-3955 hydrochloride
|
||
KRH-3955 hydrochloride is a CXCR4 antagonist with oral bioavailability. It effectively inhibits the binding of SDF-1α to CXCR4, exhibiting an IC 50 of 0.61 nM. Additionally, KRH-3955 hydrochloride displays high potency and selectivity as an inhibitor of X4 HIV-1, with an EC 50 ranging from 0.3 to 1.0 nM. | |||
T69583 | AMD-3451 trihydrochloride | ||
AMD-3451 trihydrochloride is a CCR5/CXCR4 dual antagonist that may be useful in the treatment of HIV. | |||
T25523 |
ICT5040
ICT-5040,ICT 5040 |
||
ICT5040 is a CXCR4 antagonist. |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T3396 |
Baohuoside I
Icariside-II,宝藿苷I,Icariin-II,宝藿苷 I |
Apoptosis; CXCR | Apoptosis; Autophagy; GPCR/G Protein; Immunology/Inflammation |
Baohuoside I (Icariside-II) 是从朝鲜淫羊藿中得到的一种黄酮类天然产物,是CXCR4抑制剂,抑制 CXCR4 的表达,诱导凋亡,具有抗肿瘤活性。 | |||
T6S1315 |
Oroxylin A
千层纸素A,6-Methoxybaicalein,Baicalein 6-methyl ether |
Virus Protease; HIF/HIF Prolyl-Hydroxylase; Autophagy | Autophagy; Chromatin/Epigenetic; Metabolism; Microbiology/Virology |
Oroxylin A (Baicalein 6-methyl ether) 是一种有活性的黄酮,具有较强的抗癌作用。 |